Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis

BMC Musculoskeletal Disorders

Volumn 17, Issue 1, 2016, Pages

  Matcham, Faith ^a   Norton, Sam ^a   Steer, Sophia ^a   Hotopf, Matthew ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Depression; Rheumatoid Arthritis; SF 36

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; REVIEW; RHEUMATOID ARTHRITIS; SCREENING; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; AREA UNDER THE CURVE; FEASIBILITY STUDY; HEALTH SURVEY; MAJOR DEPRESSION; MASS SCREENING; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; DEPRESSIVE DISORDER, MAJOR; FEASIBILITY STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84969750167     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-016-1083-y     Document Type: Review

References (21)

1. Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Sem Arth Rheum. 2014;44:123-30.
2. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52:2136-48.
3. Spitzer RL. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA. 1994;272:174-56.
4. Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev. 2015;39:16-29.
5. Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomised controlled trial. Rheumatology. 2016;55:268-78.
6. Rathbun AM, Reed GQ, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology. 2013;52:1785-94.
7. Kalyoncu U, Dougados M, Daurès J-P, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2009;68:183-90.
8. Ware JEJ, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473-83.
9. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440-4.
10. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167-78.
11. Rayner L, Matcham F, Hutton J, Stringer C, Dobson J, Steer S, et al. Embedding integrating mental health assessment in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatr. 2014;36:318-24.
12. Silveira E, Taft C, Sundh V, Waern M, Palsson S, Steen B. Performance of the SF-36 Health Survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual Life Res. 2005;14:1263-74.
13. National Institute of Clinical Excellent (NICE). Depression in adults with a chronic physical health problem: Treatment and management. NICE Clinical Guidance 91. London: National Institute for Health and Clinical Excellence; 2015.
14. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004;78:131-40.
15. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-7.
16. National Institute of Clinical Excellent (NICE). Rheumatoid arthritis: The management of rheumatoid arthritis in adults. NICE Clinical Guidance 79. London: National Institute for Health and Clinical Excellence; 2009.
17. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007;66:407-9.
18. Ware KE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston: Health Institute, New England Medical Center; 1993.
19. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306:1437-40.
20. Jaeschke R, Guyatt GH, Sackett DL, Guyatt G, Bass E, Brill-Edwards P, et al. Users' guides to the medical literature. III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703-7.
21. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res. 2010;62:647-56.